Curanex Pharmaceuticals (CURX) vs Lexaria Bioscience (LEXX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Curanex Pharmaceuticals is the larger company by market cap ($8.3 million vs $7.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CURX | LEXX |
|---|---|---|
| Share price | $5.31 | $3.32 |
| Market cap | $8.33M | $6.99M |
| 1-day change | +11.55% | -1.19% |
| EPS (TTM) | $-7.80 | $-5.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.94 | $21.60 |
| 52-week low | $3.58 | $2.77 |
| Distance from 52-week high | -68.65% | -84.63% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2384.94% |
| Average volume | 19.85K | 62.36K |
| Shares outstanding | 1.57M | 2.11M |
| Employees | 6 | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Lexaria Bioscience
LEXX stock →Lexaria Bioscience Corp. operates as a biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
CURX vs LEXX FAQ
Which is bigger, Curanex Pharmaceuticals or Lexaria Bioscience?
Curanex Pharmaceuticals (CURX) is larger, with a market capitalization of $8.33M compared with $6.99M for Lexaria Bioscience (LEXX).
Are Curanex Pharmaceuticals and Lexaria Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.